Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The objective of this study will be to prospectively evaluate the response of a continuous infusion of recombinant human antithrombin concentrate (rhAT) (ATRYN®) to achieve and maintain the AT activity within a specified range in adult patients that require extracorporeal membrane oxygenation (ECMO) following cardiopulmonary bypass (CPB) and cardiac surgery.
Epistemonikos ID: 814f484bf84418b093609f462a3a8d02843201f4
First added on: May 20, 2024